| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CORT | Common Stock | Award | $32,411 | +1,411 | +61% | $22.97 | 3,721 | 01 Jun 2023 | Direct | F1, F2, F3 |
| transaction | CORT | Common Stock | Award | $0 | +1,411 | +38% | $0.000000 | 5,132 | 01 Jun 2023 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on June 1, 2023. |
| F2 | In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. |
| F3 | Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| F4 | Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. |
The power of attorney under which this form was signed is on file with the Commission.